Person subject to the notification requirement

Name: Erkki Veikkolainen

Position: Member of the Board of Directors

Notification type: Initial Notification

Reference number: 743700NFG5W5I59OVX65_20210514092638_2

Issuer: Bittium Corporation

LEI: 743700NFG5W5I59OVX65

Transaction date: May 12, 2021

Venue: XHEL

Instrument: Share

ISIN: FI0009007264

Nature of transaction: Receipt of a Share-Based Incentive

Transaction details

Volume: 211, unit price: 6.66000 EUR

Volume: 21, unit price: 6.66000 EUR

Volume: 61, unit price: 6.65000 EUR

Volume: 200, unit price: 6.64000 EUR

Volume: 11, unit price: 6.64000 EUR

Volume: 2, unit price: 6.62000 EUR

Volume: 50, unit price: 6.62000 EUR

Volume: 150, unit price: 6.62000 EUR

Volume: 350, unit price: 6.62000 EUR

Volume: 150, unit price: 6.62000 EUR

Volume: 150, unit price: 6.62000 EUR

Volume: 2, unit price: 6.62000 EUR

Volume: 8, unit price: 6.62000 EUR

Volume: 305, unit price: 6.62000 EUR

Volume: 626, unit price: 6.51000 EUR

Volume: 150, unit price: 6.42000 EUR

Volume: 14, unit price: 6.42000 EUR

Volume: 45, unit price: 6.42000 EUR

Volume: 129, unit price: 6.42000 EUR

Aggregated transactions

Volume: 2,635

Volume weighted average price: 6.57403 EUR

Oulu, May 17, 2021

Hannu Huttunen

CEO

Further information:

Kari Jokela

Chief Legal Officer

Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki Oy

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

.

(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE